Funder
the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea
Basic Research Program, National Research Foundation of Korea, Ministry of Science, ICT and Future Planning
Publisher
Public Library of Science (PLoS)
Reference34 articles.
1. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature;AA Argyriou;Blood,2008
2. Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma;AK Stewart;N Engl J Med,2015
3. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study;MA Dimopoulos;Lancet Oncol,2016
4. High-Dose Carfilzomib and Dexamethasone As First-Line Treatment in Symptomatic Multiple Myeloma;TM Mark;Blood,2015
5. From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes;KB Kim;Nat Prod Rep,2013
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献